Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1087057108330111v1
14/3/219    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Baugh, C.
Right arrow Articles by Thompson, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baugh, C.
Right arrow Articles by Thompson, P. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

SCANTM—A High-Throughput Assay for Detecting Small Molecule Binding to RNA Targets

Chris Baugh, Shaohui Wang, Bin Li, James R. Appleman, and Peggy A. Thompson*

* To whom correspondence should be addressed. E-mail: pthompson{at}anadyspharma.com.


   Abstract
A novel optical-based high-throughput screening technology has been developed for increasing the rate of discovering chemical leads against RNA targets. SCANTM (Screen for Compounds with Affinity for Nucleic acids) is an affinity-based assay that identifies small molecules that bind and recognize structured RNA elements. This technology provides the opportunity to conduct high-throughput screening of a new class of targets—RNA. SCANTM offers many attractive features including a simple homogeneous format, low screening costs, and the ability to use common laboratory equipment. A SCANTM assay was developed for the HCV IRES Loop IIId RNA domain. A high-throughput screen of our entire compound library resulted in the identification of small molecule ligands that bind to Loop IIId. The Z' values were greater than 0.8, showing this to be a robust high-throughput screening assay. A correlation between SCANTM EC50 and KD values is reported suggesting the ability to use the assay for compound optimization. (Journal of Biomolecular Screening XXXX:xx-xx)

First published on February 11, 2009, doi:10.1177/1087057108330111

Journal of Biomolecular Screening 2009;14:219.

A more recent version of this article appeared on March 1, 2009


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?